Results Healthcare Appoints New Managing Director

Healthcare corporate finance and strategy specialist Results Healthcare has appointed life sciences industry veteran Nick Hyde as managing director.

With more than 25 years of pharmaceutical and life sciences business experience, Hyde spent 15 years as head of various manufacturing and business departments at ICI. As the ICI business transitioned, he became director of operations for Zeneca’s Life Science Molecules business and then spent two years as vice president of Avecia Pharmaceuticals, culminating in the supervision of more than 700 manufacturing, R&D and commercial staff across four sites in the United Kingdom and overseas, and the integration of acquisitions in North America.
 
Hyde then became global business leader of the Dowpharma business unit of Dow Chemical Company, and was a key member of the team which successfully divested the United Kingdom arm of the business. During this six-year period, he led the consolidation of all of Dow Chemical’s service and technology offerings to the pharmaceutical and biotech industries, which included the creation of two U.S.-based biotech start ups.
 
Since leaving Dow in 2008, the Cambridge University engineering graduate has worked on various major asset divestments for pharmaceutical clients in addition to his work with Cambridge-area medtech startup companies. He currently is a director of Inotec AMD Ltd. and chairman of The Diabetic Boot Company.
 
“Nick’s industry experience, depth of knowledge and leadership skills will prove invaluable as we continue our business growth,” said Results Healthcare Managing Director Kevin Bottomley. “Having worked with Nick previously, I am well aware of the strengths that he brings to our team and am excited that he has chosen to join us at this stage in the company’s development.”
 
“Results Healthcare gives me the opportunity to continue to work with clients in both the pharmaceutical and medtech sectors, helping them to reshape their capabilities, manage strategic change, raise the funding they need to bring exciting new products to market and ultimately find the right corporate partners,” Hyde said. “Doing this within a large group like Results and helping to build on the strong franchise of the business is an exciting new challenge for me.”
 
Established in 2012 in recognition of a client need for a specialist team with dedicated skills in the healthcare, pharmaceutical and biotech sectors, Results Healthcare is part of the global M&A advisory business Results International, which was established in 1991.

Results Healthcare provides strategic business advice and lead advisory corporate finance expertise to the healthcare industries.  The company advises on sell side transactions, buy side mandates; including public to private transactions, venture capital and private equity fund raising, MBOs, R&D site evaluations and divestments, company and product valuations, and licensing transactions.

In total, Results Healthcare personnel have successfully concluded more than 75 transactions in the last 10 years.